Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hearing Loss and Osteoporosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03895333
Recruitment Status : Recruiting
First Posted : March 29, 2019
Last Update Posted : March 29, 2019
Sponsor:
Information provided by (Responsible Party):
Pınar Kadirogulları, Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary:
To compare the audiological profiles in postmenopausal women with and without osteoporosis and to examine the pattern of hearing loss in osteoporotic patients. postmenopausal women will be separated as normal, osteopenic and osteoporotic according to bone mineral densitometry results. The evaluation of hearing test will be done in these groups and the results will be compared between the groups.

Condition or disease Intervention/treatment
Hearing Loss Osteoporosis, Postmenopausal Other: Audiological profiling and bone mineral densitometry measurement

Layout table for study information
Study Type : Observational
Estimated Enrollment : 160 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Audiological Profiling in Postmenopausal Women With Osteoporosis
Actual Study Start Date : March 1, 2019
Estimated Primary Completion Date : March 1, 2020
Estimated Study Completion Date : March 1, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
study group
women with hearing loss and osteoporosis will develop the study group.
Other: Audiological profiling and bone mineral densitometry measurement
bone mineral densitometry measurements and hearing test patients, osteoporosis according to whether the hearing test will be analyzed.

control group
women who have hearing loss but have no osteoporosis will constitute the control group.
Other: Audiological profiling and bone mineral densitometry measurement
bone mineral densitometry measurements and hearing test patients, osteoporosis according to whether the hearing test will be analyzed.




Primary Outcome Measures :
  1. hearing test results [ Time Frame: 1 week ]
    hearing test results will be examined; Hearing loss result: test passed or test will be recorded as not passed.

  2. bone mineral densitometry measurements [ Time Frame: 1 week ]
    bone mineral densitometry measurements of patients with hearing test. those with bone loss will be evaluated as osteoporosis.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   45 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Sampling Method:   Non-Probability Sample
Study Population
Postmenopausal women who had hearing test between the ages of 45-60 formed the study group
Criteria

Inclusion Criteria:

  • Between 45-60 years
  • postmenopausal women

Exclusion Criteria:

  • Women over 60 years old,
  • acute or chronic otitis media,
  • ear surgery,
  • use of ototoxic drugs,
  • congenital hearing loss,
  • previous long-term steroid use,
  • malignant or benign neoplasm of the brain,
  • Patients with a history of exposure to noise were excluded from the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03895333


Locations
Layout table for location information
Turkey
Kanuni Sultan Süleyman Training and Research Hospital Recruiting
Istanbul, Turkey, 33404
Contact: pınar kadiroğulları, MD    +095054947235    pinarsezer33@hotmail.com   
Sponsors and Collaborators
Kanuni Sultan Suleyman Training and Research Hospital

Layout table for additonal information
Responsible Party: Pınar Kadirogulları, Principal investigator, M.D, Department of Obstetrics and GynecologyR, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier: NCT03895333     History of Changes
Other Study ID Numbers: 2019.01.01
First Posted: March 29, 2019    Key Record Dates
Last Update Posted: March 29, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Pınar Kadirogulları, Kanuni Sultan Suleyman Training and Research Hospital:
Bone mineral density
Postmenopause

Additional relevant MeSH terms:
Layout table for MeSH terms
Osteoporosis
Osteoporosis, Postmenopausal
Hearing Loss
Deafness
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms